Joyce K. Randolph

908 total citations
23 papers, 781 citations indexed

About

Joyce K. Randolph is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Joyce K. Randolph has authored 23 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Toxicology. Recurrent topics in Joyce K. Randolph's work include Cancer therapeutics and mechanisms (11 papers), DNA Repair Mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Joyce K. Randolph is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), DNA Repair Mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Joyce K. Randolph collaborates with scholars based in United States. Joyce K. Randolph's co-authors include David A. Gewirtz, Frank A. Fornari, Jack C. Yalowich, M K Ritke, I. David Goldman, J. Courtland White, Michael S. Orr, W. David Jarvis, Steven Grant and Amy Ellis and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Archives of Biochemistry and Biophysics.

In The Last Decade

Joyce K. Randolph

23 papers receiving 755 citations

Peers

Countries citing papers authored by Joyce K. Randolph

Since Specialization

Citations

This map shows the geographic impact of Joyce K. Randolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce K. Randolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce K. Randolph more than expected).

Fields of papers citing papers by Joyce K. Randolph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce K. Randolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce K. Randolph. The network helps show where Joyce K. Randolph may publish in the future.

Co-authorship network of co-authors of Joyce K. Randolph

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce K. Randolph. A scholar is included among the top collaborators of Joyce K. Randolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce K. Randolph. Joyce K. Randolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rb Dephosphorylation and Suppression of E2F Activity in Human Breast Tumor Cells Exposed to a Pharmacological Concentration of Estradiol 2001 ·Archives of Biochemistry and Biophysics ·David A. Gewirtz, (unknown), Joyce K. Randolph, (unknown), Kristoffer Valerie, (unknown), Niharika Nath, Srikumar Chellappan	3
2	Induction of DNA Damage, Inhibition of DNA Synthesis, and Suppression of c-myc Expression by the Topoisomerase I Inhibitor, Camptothecin, in MCF-7 Human Breast Tumor Cells 1998 ·Biochemical Pharmacology ·(unknown), Frank A. Fornari, Joyce K. Randolph, Michael S. Orr, David A. Gewirtz	13
3	Induction of DNA damage, inhibition of DNA synthesis and suppression of c- myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line 1998 ·Cancer Chemotherapy and Pharmacology ·David A. Gewirtz, Joyce K. Randolph, (unknown), Michael S. Orr, Frank A. Fornari	24
4	Ionizing Radiation and Teniposide Increase p21waf1/cip1 and Promote Rb Dephosphorylation but Fail to Suppress E2F Activity in MCF-7 Breast Tumor Cells 1997 ·Molecular Pharmacology ·Michael S. Orr, (unknown), Sujatha Sundaram, Joyce K. Randolph, (unknown), David A. Gewirtz	11
5	Growth arrest and non-apoptotic cell death associated with the suppression of c-myc Expression in MCF-7 breast tumor cells following acute exposure to doxorubicin 1996 ·Biochemical Pharmacology ·Frank A. Fornari, W. David Jarvis, Steven Grant, Michael S. Orr, Joyce K. Randolph, (unknown), David A. Gewirtz	63
6	Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase 11 inhibitor, VM-26 1995 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Michael S. Orr, Frank A. Fornari, Joyce K. Randolph, David A. Gewirtz	7
7	Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells 1994 ·Biochemical Pharmacology ·Roderick T. Bunch, Lawrence F. Povirk, Michael S. Orr, Joyce K. Randolph, Frank A. Fornari, David A. Gewirtz	18
8	Antagonism between tamoxifen and doxorubicin in the MCF-7 human breast tumor cell line 1994 ·Biochemical Pharmacology ·(unknown), Joyce K. Randolph, David A. Gewirtz	32
9	Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. 1994 ·Molecular Pharmacology ·Frank A. Fornari, Joyce K. Randolph, Jack C. Yalowich, M K Ritke, David A. Gewirtz	367
10	Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression. 1993 ·PubMed ·David A. Gewirtz, Michael S. Orr, Frank A. Fornari, Joyce K. Randolph, Jack C. Yalowich, M K Ritke, Lawrence F. Povirk, Roderick T. Bunch	17
11	Components of intrinsic drug resistance in the rat hepatoma 1992 ·Biochemical Pharmacology ·Amy Ellis, (unknown), Roderick T. Bunch, (unknown), Joyce K. Randolph, Lawrence Boise, Paul Swerdlow, Leonard A. Zwelling, Michael Hinds, Saul Yanovich, David A. Gewirtz	8
12	Biochemical lesions in DNA associated with the antiproliferative effects of mitoxantrone in the hepatoma cell 1990 ·Biochemical Pharmacology ·(unknown), Joyce K. Randolph, Barbara R. Conway, David A. Gewirtz	12
13	Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage. 1989 ·PubMed ·(unknown), Amy Ellis, Joyce K. Randolph, (unknown)	6
14	Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization. 1989 ·PubMed ·David A. Gewirtz, Amy Ellis, Joyce K. Randolph, Saul Yanovich, Paul Swerdlow, Lawrence F. Povirk, Jack C. Yalowich	2
15	Induction of methotrexate release from rat hepatocytes in suspension by α-adrenergic agents: Involvement of calcium and metabolic energy 1985 ·Archives of Biochemistry and Biophysics ·David A. Gewirtz, Joyce K. Randolph, (unknown)	1
16	Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension. 1984 ·PubMed ·David A. Gewirtz, (unknown), Joyce K. Randolph	11
17	Induction of Taurocholate Release from Isolated Rat Hepatocytes in Suspension by α-Adrenergie Agents and Vasopressin: Implications for Control of Bile Salt Secretion 1984 ·Hepatology ·David A. Gewirtz, Joyce K. Randolph, David Goldman	19
18	Catecholamine-induced release of the folic acid analogue, methotrexate, from rat hepatocytes in suspension. An alpha-adrenergic phenomenon. 1982 ·Molecular Pharmacology ·David A. Gewirtz, Joyce K. Randolph, I. David Goldman	8
19	Efflux in isolated hepatocytes as a possible correlate of secretion in, vivo: Induced exit of the folic acid analog methotrexate, by dibutyryl cyclic AMP or isobutyl methyl xanthine 1981 ·Biochemical and Biophysical Research Communications ·David A. Gewirtz, Joyce K. Randolph, I. David Goldman	8
20	Potent bile salt and organic anion inhibition of methotrexate uptake and accumulation in the freshly isolated rat hepatocyte. 1980 ·PubMed ·David A. Gewirtz, Joyce K. Randolph, I. David Goldman	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact